首位患者-话题@MedSci - 梅斯（MedSci）

#首位患者#

9篇内容 | 975人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2038341, encodeId=1a562038341e5, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=Neuraptive Therapeutics宣布NTX-001预防面瘫的2期试验入组首位患者，并公布NTX-001治疗外伤导致的外周神经损伤的2期研究的最新进展, objectType=article, longId=733070, objectId=b592e3307065, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b592e3307065, replyNumber=0, likeNumber=102, createdTime=2022-11-04, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b592e3307065, moduleTitle=Neuraptive Therapeutics宣布NTX-001预防面瘫的2期试验入组首位患者，并公布NTX-001治疗外伤导致的外周神经损伤的2期研究的最新进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b592e3307065)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2038342, encodeId=de30203834208, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=NANOBIOTIX与联拓生物宣布，用于评估NBTXR3治疗头颈癌的NANORAY-312 III期试验在亚洲完成首位患者招募, objectType=article, longId=738601, objectId=0e2de3860180, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e2de3860180, replyNumber=0, likeNumber=77, createdTime=2022-12-18, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e2de3860180, moduleTitle=NANOBIOTIX与联拓生物宣布，用于评估NBTXR3治疗头颈癌的NANORAY-312 III期试验在亚洲完成首位患者招募, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0e2de3860180)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2038340, encodeId=a4a6203834068, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=Rapid Medical的DISTALS中风试验首位患者入组——为新发缺血性中风患者群体提供治疗, objectType=article, longId=728824, objectId=12b0e288243b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12b0e288243b, replyNumber=0, likeNumber=85, createdTime=2022-11-25, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12b0e288243b, moduleTitle=Rapid Medical的DISTALS中风试验首位患者入组——为新发缺血性中风患者群体提供治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=12b0e288243b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2038339, encodeId=cb5e203833916, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=IMU-838联合Oseltamivir治疗中重度COVID-19的II期临床试验：首位患者已入组, objectType=article, longId=198175, objectId=65311981e586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65311981e586, replyNumber=0, likeNumber=71, createdTime=2020-11-19, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65311981e586, moduleTitle=IMU-838联合Oseltamivir治疗中重度COVID-19的II期临床试验：首位患者已入组, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=65311981e586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2038338, encodeId=e930203833857, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=Leronlimab（PRO 140）治疗COVID-19的IIb / III期临床试验：首位患者入组, objectType=article, longId=192391, objectId=50af192391d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50af192391d8, replyNumber=0, likeNumber=91, createdTime=2021-02-11, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50af192391d8, moduleTitle=Leronlimab（PRO 140）治疗COVID-19的IIb / III期临床试验：首位患者入组, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=50af192391d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2038336, encodeId=d5142038336e0, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=Moderna宣布首位患者参与其mRNA-3704治疗甲基丙二酸血症的1/2期研究, objectType=article, longId=187859, objectId=fd2d18e859d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd2d18e859d8, replyNumber=0, likeNumber=86, createdTime=2020-03-03, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd2d18e859d8, moduleTitle=Moderna宣布首位患者参与其mRNA-3704治疗甲基丙二酸血症的1/2期研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fd2d18e859d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2038337, encodeId=f8af203833e71, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=英国首位患者在NHS内接受诺华的Luxturna基因疗法治疗先天性黑蒙病, objectType=article, longId=188484, objectId=ca9118848477, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca9118848477, replyNumber=0, likeNumber=87, createdTime=2020-07-24, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca9118848477, moduleTitle=英国首位患者在NHS内接受诺华的Luxturna基因疗法治疗先天性黑蒙病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ca9118848477)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2038335, encodeId=81942038335c9, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=Rapid Medical：TIGERTRIEVER急性缺血性中风注册研究招募到首位患者, objectType=article, longId=113789, objectId=74c0113e8995, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74c0113e8995, replyNumber=0, likeNumber=73, createdTime=2018-01-05, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74c0113e8995, moduleTitle=Rapid Medical：TIGERTRIEVER急性缺血性中风注册研究招募到首位患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=74c0113e8995)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2038334, encodeId=e0ea203833443, content=<a href='/topic/show?id=77dc10129e89' target=_blank style='color:#2F92EE;'>#首位患者#</a>, objectTitle=青大附院“沃森”上岗接诊首位患者, objectType=article, longId=97364, objectId=324a9e36452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=324a9e36452, replyNumber=0, likeNumber=86, createdTime=2018-03-30, rootId=0, userName=ms7524819409032184, userId=ac342500190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=324a9e36452, moduleTitle=青大附院“沃森”上岗接诊首位患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=324a9e36452)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

首位患者

2020-05-29

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

Neuraptive Therapeutics宣布NTX-001预防面瘫的2期试验入组首位患者，并公布NTX-001治疗外伤导致的外周神经损伤的2期研究的最新进展

2022-11-04

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

NANOBIOTIX与联拓生物宣布，用于评估NBTXR3治疗头颈癌的NANORAY-312 III期试验在亚洲完成首位患者招募

2022-12-18

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

Rapid Medical的DISTALS中风试验首位患者入组——为新发缺血性中风患者群体提供治疗

2022-11-25

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

IMU-838联合Oseltamivir治疗中重度COVID-19的II期临床试验：首位患者已入组

2020-11-19

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

Leronlimab（PRO 140）治疗COVID-19的IIb / III期临床试验：首位患者入组

2021-02-11

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

Moderna宣布首位患者参与其mRNA-3704治疗甲基丙二酸血症的1/2期研究

2020-03-03

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

英国首位患者在NHS内接受诺华的Luxturna基因疗法治疗先天性黑蒙病

2020-07-24

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

Rapid Medical：TIGERTRIEVER急性缺血性中风注册研究招募到首位患者

2018-01-05

ms7524819409032184 (审核中...)

前往app查看评论内容

#首位患者#

青大附院“沃森”上岗接诊首位患者

2018-03-30

科室
- - 订阅+
  - 更多科室
工具
服务